In animal models, agonists of AT2 receptors improve memory and reduce brain damage, indicating their potential benefits in cognition [70] and mitigating cognitive deficits through increased neurogenesis, particularly in traumatic brain injury [71]. Here, AGTR2 is linked to injury.